General articleTherapeutic control of blood pressure in the hypertension detection and follow-up program☆,☆☆
References (20)
- et al.
Role of blood pressure control in preventing complications of hypertension
Lancet
(1964) - et al.
Systolic versus diastolic blood pressure and risk of coronary heart disease
- et al.
Hypertension: A community problem
Amer. J. Med.
(1972) - et al.
Effects of treatment in hypertension: Results of a controlled study
J. Chron. Dis.
(1966) - et al.
The variability of measurements of casual blood pressure
Clin. Sci.
(1966) Hypertension 1973: Treatment—why and how
Ann. Intern. Med.
(1973)- et al.
Predisposition to atherosclerosis in the head, heart and legs
- et al.
The aetiology of essential hypertension: I, The arterial pressure in the general population
Clin. Sci.
(1954) Blood pressure studies in fourteen communities: A two-stage screen for hypertension
JAMA
(1977)INSERM
(1973)
There are more references available in the full text version of this article.
Cited by (39)
Recruitment in the Hypertension Detection and Follow-up Program
1987, Controlled Clinical TrialsAdverse effects of antihypertensive medications in the Hypertension Detection and Follow-up Program
1986, Progress in Cardiovascular DiseasesA hypertension treatment program at the workplace to complement community care
1985, Preventive MedicineA survey of blood pressure in the state of Maryland
1983, Preventive MedicineEffect of antihypertensive drugs retention using multilevel cox model
2018, Iranian Journal of Epidemiology
- ☆
The research upon which this publication is based was performed pursuant to Contracts N01-HV-124 (33–42), N01-HV-229 (31, 37, 38, 39, 45), and N01-HV-32933, with the National Heart, Lung, and Blood Institute, NIH, Department of Health, Education and Welfare.
- ☆☆
Requests for reprints should be addressed to: Scientific Project Officer, Hypertension Detection and Follow-up Program, DHVD, National Heart, Lung and Blood Institute, NIH, Federal Building, Room 404, 7550 Wisconsin Avenue, Bethesda, Md. 20014.
- 3
Members of the Writing Committee: M. Donald Blaufox, M.D., Ph.D.; David Curb, M.D.; Alex Kralios, M.D.; B. Frank Polk, M.D., M.Sc. (Chairperson); and Myra Tyler, M.D.
Copyright © 1979 Published by Elsevier Inc.